![Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populat]()
Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populatDahlke, Marion; Ng, Dik; Yamaguchi, Masayuki; Machineni, Surendra; Berger, Sergej; Canadi, Jasna; Rajman, Iris; Lloyd, Peter; Pang, Yinuo · The Journal of Clinical Pharmacology · 2015